reference/34724699

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/34724699

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
issn	0045-2068
pageRange	106405-
publicationName	Bioorganic Chemistry
startingPage	106405
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_cd8a7300775876c6deb36c23a5cc3837 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_487baf6554eb36bb22c6138d90a7c50f
bibliographicCitation	Zhao Z, Luo J, Liao H, Zheng F, Chen X, Luo J, Chen Y, Zhao K, Zhang S, Tian J, Wu T, Li Y, Li L, Yang Y, Lin C, Zhang Q, Tian Y, Pang J. Pharmacological evaluation of a novel skeleton compound isobavachin (4',7-dihydroxy-8-prenylflavanone) as a hypouricemic agent: Dual actions of URAT1/GLUT9 and xanthine oxidase inhibitory activity. Bioorg Chem. 2023 Apr;133():106405. doi: 10.1016/j.bioorg.2023.106405. PMID: 36753966.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_515eac60860fea10399e27a84583ea35 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_160fa63282301f1e688fb7c9023a0dd6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_072d8fc5ea8d873934e83abd23ee6fd2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fed6040782817c668333ad69211b0cfa http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cc38d9971db405cd9fdba414a81e00e5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_645bd5c7c983695f685c121707d165d3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b360e2e2ca0000e91a28307973da9c6e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f4246a17770a6dda6a0135c8ccc68090 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_44d774f3e13ff1d646976597257146c0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ae7afd428b111f9b215c385f5141b97e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cae66b24e97ac2d4ec590524e1b38bc9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dcf50dd406f0d3f3e0b230843d459564 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b99b776503d54f5d1a3e24da4b2961f8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9a5b89160397a53865d9160fd28ab261 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8bd13946015fda6a3afec81b06112193 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3cf65e5b8913cd0021cfbdbefbc931d2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_35d053f4fea94a58a44b51f5f24eb3b3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8e567445a37edd964f1a83f652cfe55c
date	202304
identifier	https://pubmed.ncbi.nlm.nih.gov/36753966 https://doi.org/10.1016/j.bioorg.2023.106405
isPartOf	https://portal.issn.org/resource/ISSN/0045-2068 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/20408
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Pharmacological evaluation of a novel skeleton compound isobavachin (4′,7-dihydroxy-8-prenylflavanone) as a hypouricemic agent: Dual actions of URAT1/GLUT9 and xanthine oxidase inhibitory activity
discusses	http://id.nlm.nih.gov/mesh/M0008549 http://id.nlm.nih.gov/mesh/M0022340 http://id.nlm.nih.gov/mesh/M0443033 http://id.nlm.nih.gov/mesh/M0023045
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D047309Q000737 http://id.nlm.nih.gov/mesh/D047309Q000494 http://id.nlm.nih.gov/mesh/D014969Q000037 http://id.nlm.nih.gov/mesh/D014527Q000378
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D062105 http://id.nlm.nih.gov/mesh/D051381 http://id.nlm.nih.gov/mesh/D017207 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D007668Q000187 http://id.nlm.nih.gov/mesh/D007668Q000378
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8235 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10751 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_cb94a226bbdff7de9a1d9222f4a18ade http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_1.17.3.2 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_277fbab52f54dd28ec739358c8c6ef45 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_d5714431f6dd7517db52178ecfa6d8d1 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_019cbcba25e2d68677e02aeef6754207 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_f1e4d7f806ea44eba476b32d2ebb4249 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID193679 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1175 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11609510 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_ecc266125c8edd0cd09261012266c141 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11167 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_10729e944ece49e59c317b7615b6471a http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8349 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_bd45b9ce9c4159fa707937f7c37b234f http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54767229

Total number of triples: 67.